Better Handling of Electronic Communications During Government Investigations and Discovery: What Health Care Companies Can Learn from Other Industries
01 July 2022
In today’s increasingly complex and ever-changing health care business climate, companies embroiled in government investigations or litigation often find themselves struggling to comply with Department of Justice civil investigative demands (CIDs), subpoenas, or document requests. Even under the best of circumstances, document collection, processing, and review are time consuming and expensive. Moreover, CIDs and document requests in false claims and other government investigations are often very broad and have unrealistic deadlines.
Read the full article by clicking here.
This article was published by the American Health Law Association and is reprinted here by permission.
Author(s)
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.